Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Intercept Pharmaceuticals Company Profile (NASDAQ:ICPT)

Consensus Ratings for Intercept Pharmaceuticals (NASDAQ:ICPT) (?)
Ratings Breakdown: 2 Hold Rating(s), 9 Buy Rating(s)
Consensus Rating:Buy (Score: 2.82)
Consensus Price Target: $454.20 (88.82% upside)

Current Analysts' Coverage Summary for Intercept Pharmaceuticals (NASDAQ:ICPT)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/29/2014NomuraUpgradeNeutral -> Buy$323.00ViewTweet This Rating  Share This Rating on StockTwits
7/14/2014Deutsche BankInitiated CoverageBuy$395.00ViewTweet This Rating  Share This Rating on StockTwits
7/2/2014Goldman SachsInitiated CoverageNeutral$265.00ViewTweet This Rating  Share This Rating on StockTwits
6/30/2014RBC CapitalInitiated CoverageOutperform$425.00ViewTweet This Rating  Share This Rating on StockTwits
6/27/2014Summer StreetReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
6/26/2014Leerink SwannInitiated CoverageMarket Perform$270.00ViewTweet This Rating  Share This Rating on StockTwits
5/8/2014OppenheimerLower Price TargetOutperform$525.00 -> $499.00ViewTweet This Rating  Share This Rating on StockTwits
4/14/2014Needham & Company LLCReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
3/14/2014Citigroup Inc.Boost Price TargetBuy$600.00 -> $700.00ViewTweet This Rating  Share This Rating on StockTwits
2/10/2014WedbushBoost Price Target$449.00 -> $493.00ViewTweet This Rating  Share This Rating on StockTwits
1/13/2014BMO Capital MarketsReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
1/10/2014Janney Montgomery ScottBoost Price Target$300.00ViewTweet This Rating  Share This Rating on StockTwits
1/10/2014Bank of AmericaBoost Price TargetBuy$81.00 -> $872.00ViewTweet This Rating  Share This Rating on StockTwits
11/12/2012Brean CapitalInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/31/2012 forward)